Back to top

aTyr Pharma Faces Legal Storm After Trial Failure

In a dramatic turn of events, aTyr Pharma, Inc. finds itself at the center of a class action lawsuit following the disappointing results of its Efz...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

aTyr Pharma, Inc. (ATYR)